HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT
HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT, published by HL7 International Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/standardhealth/fsh-ae/ and changes regularly. See the Directory of published versions
<MedicationAdministration xmlns="http://hl7.org/fhir">
<id value="medadmin-doxorubicin-persona-2"/>
<meta>
<profile
value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationAdministration</b><a name="medadmin-doxorubicin-persona-2"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationAdministration "medadmin-doxorubicin-persona-2" </p><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/mcode/2021May/StructureDefinition-mcode-cancer-related-medication-administration.html">Cancer-Related Medication Administration</a></p></div><p><b>status</b>: completed</p><p><b>category</b>: Outpatient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-medicationrequest-category.html">MedicationRequest Category Codes</a>#outpatient)</span></p><p><b>medication</b>: doxorubicin hydrochloride 20 MG per 10 ML Injection <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#1790099)</span></p><p><b>subject</b>: <a href="Patient-PatientPersona2.html">Patient/PatientPersona2</a> " C."</p><p><b>effective</b>: 2020-12-01</p><p><b>reasonReference</b>: <a href="Condition-primary-cancer-condition-persona-2.html">Condition/primary-cancer-condition-persona-2</a></p><p><b>request</b>: <a href="MedicationRequest-medrequest-doxorubicin-persona-2.html">MedicationRequest/medrequest-doxorubicin-persona-2</a></p><p><b>note</b>: doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2020-12-01)</p><h3>Dosages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style="display: none">*</td><td>Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#47625008)</span></td><td>105.96 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>
</text>
<status value="completed"/>
<category>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/medicationrequest-category"/>
<code value="outpatient"/>
</coding>
</category>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="1790099"/>
<display value="doxorubicin hydrochloride 20 MG per 10 ML Injection"/>
</coding>
</medicationCodeableConcept>
<subject>🔗
<reference value="Patient/PatientPersona2"/>
</subject>
<effectiveDateTime value="2020-12-01"/>
<reasonReference>🔗
<reference value="Condition/primary-cancer-condition-persona-2"/>
</reasonReference>
<request>🔗
<reference value="MedicationRequest/medrequest-doxorubicin-persona-2"/>
</request>
<note>
<authorReference>🔗
<reference
value="Practitioner/us-core-practitioner-nancy-oncology-nurse"/>
</authorReference>
<time value="2020-12-01"/>
<text
value="doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects."/>
</note>
<dosage>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous route (qualifier value)"/>
</coding>
</route>
<dose>
<value value="105.96"/>
<unit value="mg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</dose>
</dosage>
</MedicationAdministration>